Mesotherapy and Lipo Dissolve use injections to break down the fat in your targeted areas
The development of these products presents significant opportunities for ingredient companies to lead the next wave of health innovation
Editorially reviewed Last updated June 2026 How we review Part of How-To Guides
Applicable Procedure Codes: 0814T, 20930, 20931, 20939, 22899
The Real-Bari study, launched on June 26, 2026, at the Grupo Hospitalar Conceio in Porto Alegre, Rio Grande do Sul, is enrolling 250 patients with severe obesity over a two-year period to evaluate effectiveness, safety, and cost
At 24 weeks, participants receiving the highest dose achieved a mean body weight reduction of approximately 17.5%, representing some of the most substantial weight loss data observed in a Phase 2 obesity trial to date